Trials / Terminated
TerminatedNCT04357353
The Role of Platelet Rich Plasma for Erectile Dysfunction
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- Male
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
Detailed description
Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25). Intervention and Evaluation:Men who consent to join the trial will be randomized to receive either a single injection PRP or saline to the penis. All patients will have blood drawn in clinic the day of injection. Those randomized to PRP arm will have their own blood prepared and separated into the PRP. This solution of their own blood will be injected back into the penis. Follow Up: Men will be evaluated at 1 , 3, and 6 months after the injections and then asked to complete the IIEF by phone or by electronic means
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet rich plasma | PRP will be used in the experimental arm. |
| OTHER | Placebo Sham Injection | sham injection |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-11-02
- Completion
- 2022-11-02
- First posted
- 2020-04-22
- Last updated
- 2023-08-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04357353. Inclusion in this directory is not an endorsement.